These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28565934)

  • 1. Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
    Katara R; Sachdeva S; Majumdar DK
    Pharm Dev Technol; 2018 Mar; 23(3):240-246. PubMed ID: 28565934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.
    Dave V; Paliwal S; Yadav S; Sharma S
    ScientificWorldJournal; 2015; 2015():432376. PubMed ID: 25654129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
    Mathurm M; Gilhotra RM
    Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.
    Pawar PK; Majumdar DK
    Pharmazie; 2007 Nov; 62(11):853-7. PubMed ID: 18065102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro corneal permeation of diclofenac from oil drops.
    Ahuja M; Sharma SK; Majumdar DK
    Yakugaku Zasshi; 2007 Oct; 127(10):1739-45. PubMed ID: 17917432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
    Katara R; Sachdeva S; Majumdar DK
    Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
    Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
    AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
    Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
    Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
    Pawar PK; Majumdar DK
    AAPS PharmSciTech; 2006 Feb; 7(1):E13. PubMed ID: 16584143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation.
    Dave V; Paliwal S
    Saudi Pharm J; 2014 Jul; 22(3):240-5. PubMed ID: 25061410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
    Dasgupta S; Dey S; Choudhury S; Mazumder B
    Expert Opin Drug Deliv; 2013 Apr; 10(4):411-20. PubMed ID: 23316798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
    Katara R; Sachdeva S; Majumdar DK
    Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
    Rhee YS; Nguyen T; Park ES; Chi SC
    Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceclofenac topical dosage forms: in vitro and in vivo characterization.
    Dua K; Pabreja K; Ramana MV
    Acta Pharm; 2010 Dec; 60(4):467-78. PubMed ID: 21169138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.
    Rathore MS; Majumdar DK
    AAPS PharmSciTech; 2006 Jul; 7(3):57. PubMed ID: 17025238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation.
    Shakeel F; Baboota S; Ahuja A; All J; Shafiq S
    Pharmazie; 2008 Aug; 63(8):580-4. PubMed ID: 18771006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
    Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.